The sinister side of Cushing's therapy

Lancet Diabetes Endocrinol. 2019 Nov;7(11):822-823. doi: 10.1016/S2213-8587(19)30312-2. Epub 2019 Sep 18.

Author

Ashley Grossman¹

Affiliation

¹ Green Templeton College, University of Oxford, Oxford OX2 6HG, UK; Barts and the London School of Medicine, Queen Mary University of London, London, UK. Electronic address: ashley.grossman@ocdem.ox.ac.uk.

PMID: 31542383
DOI: 10.1016/S2213-8587(19)30312-2

No abstract available

Publication types

Comment

MeSH terms

Adrenocorticotropic Hormone
Cushing Syndrome*
Enzyme Inhibitors
Humans
Hydrocortisone

Substances

Enzyme Inhibitors
Adrenocorticotropic Hormone
Hydrocortisone